# RhoGEF Ect2 supports RhoA activity at cell–cell junctions through desmoplakin

**Authors:** Hoda Zarkoob, Chen Y Kam, Jennifer L Koetsier, Erin McCarthy, Avinash Jaiganesh, David P Kelsell, Farah Sheikh, Lisa M Godsel, Kathleen J Green

PMC · DOI: 10.26508/lsa.202503454 · 2026-03-12

## TL;DR

This study reveals how desmoplakin helps control RhoA activity at cell junctions, which is important for heart and skin health.

## Contribution

The study identifies Ect2 as a new component of cell junctions regulated by desmoplakin.

## Key findings

- Desmoplakin promotes Ect2 localization at desmosomes and cardiac intercalated discs.
- Ect2 activity is regulated by PKC in a desmoplakin-dependent manner in cardiac myocytes.
- A truncated form of desmoplakin in Carvajal syndrome impairs Ect2 binding and localization.

## Abstract

We describe a mechanism by which the desmosome component, desmoplakin, can recruit and control the activity of the contractile signaling regulator RhoA at cardiomyocyte and keratinocyte intercellular junctions, with implications for cardiocutaneous health and disease pathogenesis.

Desmoplakin (DP) is an essential component of the desmosomal adhesion complex, tethering intermediate filaments to sites of intercellular adhesion to confer mechanical integrity to tissues. As a frequent target for mutation in cardiocutaneous syndromes that vary widely in phenotype, DP’s roles as a signaling hub are rapidly emerging. Here, we identify the RhoGEF Ect2 as a previously unappreciated component of intercellular junctions in close association with DP. DP promotes the localization of Ect2 to keratinocyte desmosomes and cardiac intercalated discs, where it maintains active RhoA (Rho-GTP) at the membrane. We demonstrate that Ect2 activity is regulated by PKC in a DP-dependent manner in cardiac myocytes. Finally, a truncated form of DP expressed in patients with Carvajal syndrome associated with severe cardiocutaneous defects is impaired in its ability to bind and localize Ect2 to cell junctions in cardiomyocytes and patient keratinocytes. Our findings delineate an important relationship between a component of the desmosome and a critical regulator of actin cytoskeletal remodeling that could have widespread implications for understanding cardiac and cutaneous health and disease pathogenesis.

## Linked entities

- **Genes:** ECT2 (epithelial cell transforming 2) [NCBI Gene 1894], RHOA (ras homolog family member A) [NCBI Gene 387], desmoplakin (putative desmoplakin) [NCBI Gene 951777], PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476]
- **Proteins:** desmoplakin (putative desmoplakin), ECT2 (epithelial cell transforming 2), RHOA (ras homolog family member A), PRRT2 (proline rich transmembrane protein 2)
- **Diseases:** Carvajal syndrome (MONDO:0011581)

## Full-text entities

- **Genes:** SRPRA (SRP receptor subunit alpha) [NCBI Gene 6734] {aka DP, SRPR, Sralpha}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, ECT2 (epithelial cell transforming 2) [NCBI Gene 1894] {aka ARHGEF31}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, DSP (desmoplakin) [NCBI Gene 1832] {aka DCWHKTA, DP}
- **Diseases:** Carvajal syndrome (MESH:C535581), cardiocutaneous defects (MESH:D000013), cardiocutaneous syndromes (MESH:D013577)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12983042/full.md

---
Source: https://tomesphere.com/paper/PMC12983042